Proof of Concept study of the efficacy and tolerability of a 4-week treatment with F13640 in patients in whom the adaptation of opioid therapy of cancer pain has failed. A prospective, multinational, multicentre, randomised, double-blind, placebo-co
Proof of Concept study of the efficacy and tolerability of a 4-week treatment with F13640 in patients in whom the adaptation of opioid therapy of cancer pain has failed. A prospective, multinational, multicentre, randomised, double-blind, placebo-co
Proof of Concept study of the efficacy and tolerability of a 4-week treatment with F13640 in patients in whom the adaptation of opioid therapy of cancer pain has failed. A prospective, multinational, multicentre, randomised, double-blind, placebo-controlled study.
Statut
Status :
Terminé
Type d'étude
Phase II
Age Min.
18
Ans
Age Max.
65
Ans
Genre
Tous
Aire thérapeutique :
Système nerveux central
Maladie :
Neuropathie
Traitement :
F13640
Phase :
Phase II
Date de début de l'étude :
20 Mars 2008
End date :
03 Novembre 2008
Identifiant de l'essai :
F13640 GE 209
Identifiant EudraCT/CTIS :
2007-003249-34
Envoyer par email